OVER BEING OVERLOOKED™
Because women’s health isn’t niche—it’s non-negotiable
For us, it’s personal. We know what it feels like to be told to “wait it out” or “live with it.” We were, quite literally, sick of it. So, we started Daré Bioscience with one clear mission: to put her health first.
As a female-led biotech company of scientists, specialists and entrepreneurs, we are accelerating innovation to address the critical gaps in women’s health that are overlooked and underfunded. We’ve experienced what’s missing, understand what’s at stake—and are daring to do something about it.
“I started Daré Bioscience because I was disappointed by the lack of industry commitment to women’s health and bringing new treatments to market. I decided to do something about it.”
Sabrina Martucci Johnson
Founder & Chief Executive Officer of Daré Bioscience
From “wait it out” to “we’re on it.” And overlooked to understood.
Together, we’re swapping silence for serious science, and making her invisible solvable.
We're On a Mission
From in-depth research to real-world results, we’re committed to changing women’s lives by revolutionizing their health.
FDA-Approved Product
Completed Clinical Trials Submitted to the FDA
Spent on Women’s Health Research + Product Development
Peer-Reviewed Publications
The Daré Approach: Science That Meets Our Standards
We don’t cut corners. We use rigorous, evidence-based methods to bring our innovations to women:
- Randomized, controlled clinical trials
- Validated endpoints and meaningful effect sizes
- Published data in peer-reviewed journals
- Manufacturing under pharmaceutical Good Manufacturing Practices (GMP)
Everything from our formulations to our telehealth platform is medically credible and evidence-based—designed with providers, for women. Every recommendation is rooted in what is clinically appropriate. We’re here to serve her better, not sell her more.
"Female" isn't One Identity
Our biotech innovations are based on biology, not labels. We use ‘female’ language and pronouns inclusively of any person assigned female at birth (AFAB)—cisgender women, trans men, nonbinary, and other gender-diverse people whose biology presents unique hormonal and reproductive health needs.
Our community is broad and though our identities and journeys differ, we share a common vision: To accelerate innovation of therapeutics that see us, serve us and put our health first.